Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
Annals of Neurology|September 22, 2020
Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseAlvaro Cobo-Calvo, Anne Ruiz, Fabien Rollot, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 22, 2024
COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022Lina Jeantin, Edouard Januel, Pierre Labauge, et al.
JAMA Neurology|February 26, 2014
Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective studyMikael Cohen, Elisabeth Maillart, Ayman Tourbah, et al.
JAMA Neurology|February 12, 2024
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple SclerosisNail Benallegue, Fabien Rollot, Sandrine Wiertlewski, et al.
Neurology|April 1, 2026
Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MSApolline Tournier, Antoine Gavoille, Julie Pique, et al.
Therapeutic Advances in Neurological Disorders|July 14, 2020
Sex effects across the lifespan in women with multiple sclerosisKristen M Krysko, Jennifer S Graves, Ruth Dobson, et al.
NEJM Evidence|October 22, 2024
Infliximab versus Cyclophosphamide for Severe Behçet's SyndromeDavid Saadoun, Georgina Maalouf, Matheus Vieira, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 1, 2019
Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric studyJonathan Ciron, Alvaro Cobo-Calvo, Bertrand Audoin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 2, 2026
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosisNail Benallegue, Fabien Rollot, Pietro Iaffaldano, et al.
JAMA|March 10, 2025
High-Dose Vitamin D in Clinically Isolated Syndrome Typical of Multiple Sclerosis: The D-Lay MS Randomized Clinical TrialEric Thouvenot, David Laplaud, Christine Lebrun-Frenay, et al.
Pageof 14